Koch H R, Hillenblink M, Liappis N
Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1976;200(3):211-22. doi: 10.1007/BF01028536.
The influence of daily subcutaneous cortisol injections (10 mg/kg) on the development of cataracts in streptozotocine (STR) diabetes was studied in 6 groups of Wistar rats (n = 10). Cataracts occurred only in the two groups subjected to high STR doses (60 mg/kg). We were astonished to find that in cortisol-treated diabetic animals there were lower blood glucose levels, fewer cases of glucosuria, and less pronounced cataracts than in rats treated with STR only. As STR had been administered after the start of cortisol therapy, it is assumed that the steroid had caused a protection of pancreatic B cells against STR and the onset of a less severe diabetes.
在6组Wistar大鼠(每组n = 10)中研究了每日皮下注射皮质醇(10毫克/千克)对链脲佐菌素(STR)诱导的糖尿病大鼠白内障形成的影响。白内障仅发生在接受高剂量STR(60毫克/千克)的两组中。我们惊讶地发现,与仅接受STR治疗的大鼠相比,接受皮质醇治疗的糖尿病动物血糖水平更低,糖尿病例数更少,白内障也不那么明显。由于在皮质醇治疗开始后才给予STR,因此推测该类固醇对胰腺β细胞起到了保护作用,使其免受STR影响,并减轻了糖尿病的严重程度。